Accelerate Diagnostics Investor Presentation September 2023

Accelerate Diagnostics presented this investor deck in September 2023 outlining its rapid diagnostic testing platform and commercial strategy. The presentation covers the company's Accelerate Pheno system, partnerships with Becton Dickinson, and regulatory plans including FDA submissions for the Accelerate Arc product and Wave instrument. The deck addresses the company's market opportunity, competitive positioning, and financial outlook amid ongoing restructuring considerations.